Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 368

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1B
Chunk 368
---
    ●
    reviewing and
    advising on our drug development strategy, including the selection of therapeutic targets, the design and execution of clinical trials,
    and the regulatory pathway for approval;

    ●
    assessing our research
    pipeline and recommending changes or improvements to ensure a sustainable and diverse portfolio of drug candidates;

    ●
    evaluating our intellectual
    property strategy and overseeing the implementation of appropriate measures to protect our discoveries and inventions; and

    ●
    reviewing our manufacturing
    strategy and overseeing the quality controls put in place to meet regulatory requirements.

The
members of our Science and Technology Committee are Dr. Gilbert, Mr. Maddaluna, Dr. Martell, and Mr. Newman. Mr. Newman serves as the
Chairperson of the Science and Technology Committee.

Item
11. Executive Compensation.

Our
named executive officers for 2024, which consist of our principal executive officer and the next two most-highly compensated executive
officers who were serving as executive officers as of December 31, 2024 are:

    ●
    Jeffrey A.
    Meckler, Chief Executive Officer and Director;

    ●
    Walt. A. Linscott, Esq.,
    Chief Operating Officer; and

    ●
    Roger J. Waltzman, M.D.,
    Chief Medical Officer

80

Summary
Compensation Table

The
following table sets forth all of the compensation awarded to, earned by or paid to our named executive officers during 2024 and 2023.

    Name and Principal Position 
    Year 
    Salary ($)  
    Bonus ($)  
    Stock Awards ($)  
    Option Awards(1) ($)  
    Non-equity Incentive Plan Compensation  
    All Other Compensation(2) ($)  
    Total ($) 
  
    Jeffrey A. Meckler, 
    2024 
     575,000  
     —  
     —  
     219,421  
     287,500  
     75,296  
     1,157,217 
  
    Chief Executive Office 
    2023 
     565,000  
     —  
     —  
     134,221  
     223,175  
     78,853  
     1,001,249 
  
    Walt A. Linscott, Esq., 
    2024 
     475,000